Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women
Background and Purpose: Vulvovaginal candidiasis is considered the second mostprevalent gynecologic infection among women and one of the main reasons for referring to a gynecologist. During recent decades, probiotic usage has been defined as one of the therapeutic regimens for vaginal candidiasis ma...
Main Authors: | Zahra Vahedpoor, Mahdi Abastabar, Mojtaba Sehat, Parisa Talebian, Tayebeh Felfelian fini, Zahra Dastanpour, Iman Haghani, Ramtin Chelongarian, Mehdi Nazeri |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2021-09-01
|
Series: | Current Medical Mycology |
Subjects: | |
Online Access: | http://cmm.mazums.ac.ir/article_139763_7293c9472a866a0c2bf677aa8758ddd5.pdf |
Similar Items
-
Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
by: Zahra Vahedpoor, et al.
Published: (2022-04-01) -
Epidemiological profile and fluconazole susceptibility of patients with vulvovaginal candidiasis in northeast Iran
by: Raheleh Alhashem, et al.
Published: (2024-01-01) -
Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01) -
On the resistant pathogens problem of the recurrent vulvovaginal candidiasis
by: Yu V Dolgo-Saburova, et al.
Published: (2014-02-01) -
Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)